| Overview |
| bs-13019R-PE-Cy5 |
| DNA Polymerase Kappa/POLK Antibody, PE-Cy5 Conjugated |
| FCM |
| Human |
| Mouse, Rat, Dog, Cow, Sheep, Pig, Horse |
| Specifications |
| PE-Cy5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human DNA Polymerase Kappa/POLK |
| 1-100/870 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 51426 |
| Nucleus |
| DNA polymerase kappa; DINB protein; Short=DINP; POLK_HUMAN. |
| DNA polymerase lambda (pol Kappa), also designated DNA polymerase Kappa or Pol Beta2, is a low-fidelity polymerase which plays a role in both spontaneous and DNA damage-induced mutagenesis. Encoded by the POLL gene, pol Kappa is a member of the DNA polymerase type-X family. Pol Kappa extends primer-terminal mispairs opposite nondamaged DNA templates, suggesting that it may assist in extending mismatched base pairs during normal DNA replication. In addition, pol Kappa may play a role in the mutagenic bypass of T-T dimers. Proliferating cell nuclear antigen (PCNA), a protein essential to DNA replication, interacts with pol Kappa and thus influences the ability of pol Kappa to synthesize DNA. |
| Application Dilution |
| FCM |
1:20-100 |
Powered by Bioz